National Healthcare (NHC) Cash & Equivalents (2010 - 2026)

National Healthcare has reported Cash & Equivalents for 17 years, with the latest figure at $85.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 5.38% year-over-year to $85.5 million; the trailing twelve-month figure through Mar 2026 stood at $85.5 million (down 5.38% YoY), and the FY2025 full-year result was $18.1 million, down 76.2% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $85.5 million, up from $18.1 million in the prior quarter.
• The five-year high for Cash & Equivalents was $136.2 million in Q2 2024, with the low at $18.1 million in Q4 2025.
• Historically, Cash & Equivalents has averaged $82.0 million across 5 years, with a median of $84.8 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents jumped 125.34% — and 2025, when it tumbled 76.2%.
• National Healthcare's Cash & Equivalents stood at $58.7 million in 2022, then soared by 82.51% to $107.1 million in 2023, then dropped by 28.91% to $76.1 million in 2024, then plunged by 76.2% to $18.1 million in 2025, then surged by 372.05% to $85.5 million in 2026.
• The last three Cash & Equivalents figures came in at $85.5 million (Q1 2026), $18.1 million (Q4 2025), and $130.6 million (Q3 2025), per Business Quant data.